SEC Form 4 · accession 0001179110-18-013325
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Miles D White
Officer — Chairman and CEO · Director
Period of report
Nov 28, 2018
Accepted (ET)
Nov 30, 2018 · 5:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Nov 28, 2018 | S | 1,600 | $72.575 | D | 3,138,104 | D | |
| Common shares without par value | Nov 28, 2018 | S | 400 | $72.58 | D | 3,137,704 | D | |
| Common shares without par value | Nov 28, 2018 | S | 2,900 | $72.585 | D | 3,134,804 | D | |
| Common shares without par value | Nov 28, 2018 | S | 500 | $72.59 | D | 3,134,304 | D | |
| Common shares without par value | Nov 28, 2018 | S | 119 | $72.595 | D | 3,134,185 | D | |
| Common shares without par valueF1 | holding | — | — | — | 32,887 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of November 28, 2018.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).Form 3 of 3.